期刊文献+

肺淋巴管肌瘤病1例 被引量:1

下载PDF
导出
摘要 笔者临床治疗肺淋巴管肌瘤病(PLAM)患者1例,谨就其临床和预后探讨如下。 1病例资料 王某,女,39岁,2014年4月20日入我院。反复咳嗽、呼吸困难3年,加重半月。入院查体:T36.8℃,P 82次/min,R 25次/min,BP 110/70 mm Hg,神志清楚,精神极差,全身浅表淋巴结均未触及肿大,双侧胸廓对称无畸形,双肺呼吸动度及触觉语颤一致,双肺叩诊呈清音、呼吸音低、未闻及干湿性哕音,心率82次/min,律齐,P2〉A2,各瓣膜区未闻及病理性杂音。
作者 毛娅 蒋伟
出处 《山西中医》 2015年第6期51-52,共2页 Shanxi Journal of Traditional Chinese Medicine
  • 相关文献

参考文献6

  • 1Aubuo M C, Myers jl, Ryn JH, et al. Pulmonary lym phangiolei- om yomatosis in a man[J ]. Am J Res Crit Care M ed,2000,162 (2) :749 -752.
  • 2Johnson SR, Cordier JF, Lazor R, et al. European Respiratory So- ciety guidelines for the diagnosis and m anagem ent of lym phan gi - oleiomyomatosis [ J ]. Eur Respir J,2010 ( 5 ) : 14 - 26.
  • 3Liu F, Lunsford EP, Tong J, et al. Real - time monitoring of tu- morigenesis, dissemination, drug response in a preelinicalm odei of lymphangi oleiom yom atosistuberous sclerosis complex [ J]. PLoS One ,2012(7 ) : e38589.
  • 4GlasgowCG,E1 -Chem al y S,M oss J. Lymphaties in lymphangi o- leiom yomatosis and idiopathic pulmonary fibrosis [ J ]. Eur Respir Rev,2012,21:196 - 206.
  • 5Xu KF,Zhang P,Tian X,et al. The role of vascular endothelial- growth factor - D in diagnosis of lym phangioleiomyom atosis ( LAM ) [J]. Respir Med,2013,107:263 -268.
  • 6朱建荣,巩晓峰.肺淋巴管平滑肌瘤病的诊治进展[J].临床肺科杂志,2014,19(7):1321-1323. 被引量:2

二级参考文献15

  • 1Meraj R, Wikenheiser-Brokamp KA, Young LR, et al. Lymphangioleiomyomatosis : new concepts in pathogenesis, diagnosis, and treatment[J]. Semin Respir Crit Care Med, 2012,33:486 - 97.
  • 2Ando K, Tobino K, Kurihara M, et al. Quantitative CT analysis of small pulmonary vessels in lymphangioleiomyomatosis [ J ]. Eur JRadiol, 2012,81:3925 -30.
  • 3Ryu JH, Moss J, Beck GJ, et al. The NHLBI lymphangioleiomyo- matosis registry : characteristicsof 230 patients at enrollment [ J ]. Am J Respir Crit Care Med, 2006, 173:105 -111.
  • 4Johnson SR, Cordier JF, Lazar R, et al. European Respiratory Society guidelines for the diagnosis and management of lymphangi- oleiomyomatosisEJ]. Eur Respir J, 2010, 5:14-26.
  • 5Liu F, Lunsford EP, Tong J, et al. Real-time monitoring of tu- morigenesis, dissemination, & drug response in a preclinieal model of lymphangioleiomyomatosis/tuberous sclerosis complex [ J ]. PLoS One, 2012 ;7 : e38589.
  • 6Glasgow CG, E1-Chemaly S, Moss J. Lymphatics in lymphangio- leiomyomatosis and idiopathic pulmonary fibrosis[ J]. Eur Respir Rev ,2012,21 : 196 - 206.
  • 7Xu KF, Zhang P, Tian X, et al. The role of vascular endothelial growth factor-D in diagnosis of lymphangioleiomyomatosis (LAM) [J]. Respir Med, 2013,107:263 -8.
  • 8Maria Mavroudi, Panl Zarogoulidis, Nikolaos Katsikogiannis, et al. Lymphangioleiomyomatosis : current and future [ J]. J Thorac Dis, 2013 February; 5(1): 74-79.
  • 9Harari S, Torre O, Moss J. Lymphangioleiomyomatosis: what do we know and what are we looking for[ J] .9 Eur Respir Rev, 2011, 20:34 - 44.
  • 10Ansotegui Barrera E, Mancheno Franeh N, Vera-Sempere F, et al. Lymphangioleiomyomatosis [ J ]. Arch Bronconeumol, 2011, 47:85 - 93.

共引文献1

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部